State Board of Administration of Florida Retirement System Has $16.91 Million Position in Hologic, Inc. (HOLX)

State Board of Administration of Florida Retirement System increased its stake in Hologic, Inc. (NASDAQ:HOLX) by 0.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 412,544 shares of the medical equipment provider’s stock after purchasing an additional 1,600 shares during the quarter. State Board of Administration of Florida Retirement System owned approximately 0.15% of Hologic worth $16,906,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of HOLX. Moody National Bank Trust Division lifted its holdings in shares of Hologic by 256.4% during the 3rd quarter. Moody National Bank Trust Division now owns 27,975 shares of the medical equipment provider’s stock valued at $1,147,000 after buying an additional 20,125 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Hologic by 92.8% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 22,272 shares of the medical equipment provider’s stock valued at $913,000 after buying an additional 10,722 shares during the last quarter. Nissay Asset Management Corp Japan ADV lifted its holdings in shares of Hologic by 33.2% during the 3rd quarter. Nissay Asset Management Corp Japan ADV now owns 50,689 shares of the medical equipment provider’s stock valued at $2,077,000 after buying an additional 12,621 shares during the last quarter. Greenleaf Trust lifted its holdings in shares of Hologic by 3.9% during the 3rd quarter. Greenleaf Trust now owns 120,917 shares of the medical equipment provider’s stock valued at $4,955,000 after buying an additional 4,514 shares during the last quarter. Finally, Mesirow Financial Investment Management Equity Management acquired a new stake in shares of Hologic during the 3rd quarter valued at about $1,324,000. 98.74% of the stock is currently owned by hedge funds and other institutional investors.

HOLX opened at $41.78 on Friday. Hologic, Inc. has a twelve month low of $35.10 and a twelve month high of $45.09. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.29 and a quick ratio of 0.99. The company has a market capitalization of $11.23 billion, a P/E ratio of 18.74, a P/E/G ratio of 1.88 and a beta of 0.65.

Hologic (NASDAQ:HOLX) last posted its earnings results on Wednesday, November 7th. The medical equipment provider reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.59 by ($0.01). Hologic had a positive return on equity of 22.93% and a negative net margin of 3.46%. The company had revenue of $813.50 million during the quarter, compared to analyst estimates of $808.63 million. During the same quarter last year, the firm posted $0.50 earnings per share. The firm’s revenue for the quarter was up 1.3% compared to the same quarter last year. Equities analysts expect that Hologic, Inc. will post 2.4 earnings per share for the current year.

HOLX has been the subject of several research reports. TheStreet upgraded Hologic from a “c” rating to a “b” rating in a report on Tuesday, July 31st. Cowen reiterated a “buy” rating and set a $45.00 price target on shares of Hologic in a report on Wednesday, August 1st. Bank of America lifted their price target on Hologic from $44.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, August 1st. Jefferies Financial Group reiterated a “buy” rating and set a $50.00 price target on shares of Hologic in a report on Wednesday, August 1st. Finally, Needham & Company LLC lifted their price target on Hologic from $43.00 to $48.00 and gave the company a “buy” rating in a report on Wednesday, August 1st. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $44.41.

In other Hologic news, Director Sally Crawford sold 13,257 shares of Hologic stock in a transaction that occurred on Monday, September 17th. The stock was sold at an average price of $39.54, for a total value of $524,181.78. Following the transaction, the director now directly owns 167,701 shares of the company’s stock, valued at approximately $6,630,897.54. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Christiana Stamoulis sold 30,967 shares of Hologic stock in a transaction that occurred on Tuesday, October 2nd. The stock was sold at an average price of $40.70, for a total value of $1,260,356.90. Following the completion of the transaction, the director now directly owns 66,006 shares in the company, valued at $2,686,444.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 49,519 shares of company stock worth $2,003,965. Company insiders own 0.79% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “State Board of Administration of Florida Retirement System Has $16.91 Million Position in Hologic, Inc. (HOLX)” was reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.wkrb13.com/2018/11/10/state-board-of-administration-of-florida-retirement-system-has-16-91-million-position-in-hologic-inc-holx.html.

Hologic Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

See Also: What are the components of an earnings report?

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply